SIBN
HealthcareSI-BONE, Inc.
$19.97
+$0.18 (+0.91%)
Jan 5, 2026
Price History (1Y)
Analysis
SI-BONE, Inc. is a medical device company within the healthcare sector and medical devices industry. With a market capitalization of $866.52M, it operates on a significant scale with 349 employees. The company's financial health reflects a mixed picture. Its gross margin stands at 79.6%, indicating relatively high profitability in terms of sales. However, this is not reflected in its operating and profit margins, which are -11.1% and -11.2%, respectively, suggesting operational inefficiencies or significant losses. From a balance sheet perspective, SI-BONE has a manageable level of debt at $36.84M, compared to its cash reserves of $145.74M. Valuation metrics paint an uncertain picture. The forward P/E ratio is -40.65, which may indicate a challenging outlook for future earnings. Revenue growth has been positive, with a year-over-year increase of 20.6%. However, the lack of dividend payments means that investors do not receive any regular returns on their investment.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About SI-BONE, Inc.
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products. The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Visit website →Key Statistics
- Market Cap
- $866.52M
- P/E Ratio
- N/A
- 52-Week High
- $21.07
- 52-Week Low
- $12.50
- Avg Volume
- 526.03K
- Beta
- 0.70
Company Info
- Industry
- Medical Devices
- Exchange
- NGM
- Country
- United States
- Employees
- 349